During Mr. Robert's absence, Elisabeth DeMarse, who will remain as a member of the Board, will also serve as Interim Chief Executive Officer and President of the Company.
Departed
(interim)
Paul Roberts
Chief Executive Officer
Kubient, Inc.
Effective
2023-09-22
Successor
Elisabeth DeMarse
Filed
September 25, 2023, 7:59 PM ET
On September 22, 2023, the Board placed Paul Roberts on paid administrative leave from his positions as Chief Executive Officer, Chief Strategy Officer, and President of the Company pending an internal investigation conducted by outside legal counsel on behalf of a special committee of the Board
Departed
Brenda Battey
Executive Vice President and Chief Financial Officer
On September 20, 2023, Brenda Battey, Executive Vice President and Chief Financial Officer of the Company and the Bank, informed the Company and its board of directors that she intends to retire from the Company and the Bank in the first half of 2024 following more than 10 years of service and after a suitable replacement has been found and properly transitioned.
The Board of Directors (the “Board”) of Alcoa Corporation (the “Company”) elected Mr. William F. Oplinger to serve as President and Chief Executive Officer of the Company on September 24, 2023
Appointed
Robert E. Landry
Chief Financial Officer
Decibel Therapeutics, Inc.
Effective
2023-09-25
Filed
September 25, 2023, 7:59 PM ET
Following the Effective Time, the officers of the Company are as follows: Nouhad Husseini, Managing Director, Robert E. Landry, Chief Financial Officer, Joseph J. LaRosa, Secretary, and Leonard N. Brooks, Treasurer
Departed
Erik T. Engelson
President, Chief Executive Officer and member of the Board of Directors
Lucira Health, Inc.
Filed
September 25, 2023, 7:59 PM ET
Pursuant to the terms of the Chapter 11 Plan, on the Effective Date, Brian Ryniker will be appointed as the Liquidating Trustee and representative of the Debtor’s Estate, and Erik T. Engelson, President, Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Michael Wyse, member of the Board, and Richard Narido, Chief Financial Officer, will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Richard Narido
Chief Financial Officer
Lucira Health, Inc.
Filed
September 25, 2023, 7:59 PM ET
Pursuant to the terms of the Chapter 11 Plan, on the Effective Date, Brian Ryniker will be appointed as the Liquidating Trustee and representative of the Debtor’s Estate, and Erik T. Engelson, President, Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Michael Wyse, member of the Board, and Richard Narido, Chief Financial Officer, will each be deemed to have resigned from their respective positions as directors and officers of the Company.
On September 5, 2023, the Company filed a Current Report on Form 8-K (the “Report”) to disclose that, effective September 1, 2023, Scott Burrows succeeded Jonathan Alspaugh as the Company’s Chief Financial Officer.
On September 21, 2023, the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) appointed Herb Cross, age 51 , as its Chief Financial Officer and Corporate Secretary.
Appointed
Joshua B. Warren
Chief Financial Officer
ENVESTNET, INC.
Effective
2023-11-15
Filed
September 25, 2023, 7:59 PM ET
Joshua B. Warren will be joining Envestnet, Inc. as a senior advisor to the Company's Chief Executive Officer on or before October 9, 2023 and will become the Company's Chief Financial Officer effective November 15, 2023.
Departed
Peter D'Arrigo
Chief Financial Officer
ENVESTNET, INC.
Effective
2023-11-15
Successor
Joshua B. Warren
Filed
September 25, 2023, 7:59 PM ET
On September 25, 2023, Envestnet, Inc. (the “Company”) announced that Peter D'Arrigo will be stepping down as Chief Financial Officer effective November 15, 2023.
Appointed
Pierce H. Norton II
President and Chief Executive Officer
Magellan Midstream Partners, L.P.
Effective
2023-09-25
Filed
September 25, 2023, 7:59 PM ET
Effective as of the Effective Time, Pierce H. Norton II was appointed President and Chief Executive Officer of the General Partner
Appointed
Walter S. Hulse III
Chief Financial Officer, Treasurer and Executive Vice President, Investor Relations and Corporate Development
Magellan Midstream Partners, L.P.
Effective
2023-09-25
Filed
September 25, 2023, 7:59 PM ET
Walter S. Hulse III was appointed Chief Financial Officer, Treasurer and Executive Vice President, Investor Relations and Corporate Development of the General Partner.
Effective September 25, 2023, Ms. Shevorenkova has returned to the position of Chief Financial Officer, with Ms. Lee continuing in the position of Senior Vice President of Accounting.
the Company and Deverl Maserang, the Company’s President and Chief Executive Officer and a member of the Company’s Board of Directors (the “Board”), had agreed that Mr. Maserang’s employment with the Company would be terminated, without cause, effective September 30, 2023.
Appointed
Michael D. Leskinen
Executive Vice President and Chief Financial Officer
On September 21, 2023, the Board of Directors of United Airlines Holdings, Inc. (the “Company”) appointed Michael D. Leskinen to the position of Executive Vice President and Chief Financial Officer of the Company, effective September 21, 2023
Departed
Tracy D. Pagliara
President and Chief Executive Officer
NOS4-1, Inc.
Filed
September 22, 2023, 7:59 PM ET
Effective immediately following the consummation of the Sale, the following individuals resigned as officers of the Company and its affiliates, and their employment was terminated without cause: (i) Tracy D. Pagliara, President and Chief Executive Officer; (ii) Randall R. Lay, Executive Vice President, Chief Financial Officer and Chief Operating Officer; and (iii) Charles E. Wheelock, Senior Vice President, Chief Administrative Officer, General Counsel and Secretary.
Departed
Randall R. Lay
Executive Vice President, Chief Financial Officer and Chief Operating Officer
NOS4-1, Inc.
Filed
September 22, 2023, 7:59 PM ET
Effective immediately following the consummation of the Sale, the following individuals resigned as officers of the Company and its affiliates, and their employment was terminated without cause: (i) Tracy D. Pagliara, President and Chief Executive Officer; (ii) Randall R. Lay, Executive Vice President, Chief Financial Officer and Chief Operating Officer; and (iii) Charles E. Wheelock, Senior Vice President, Chief Administrative Officer, General Counsel and Secretary.
On September 20, 2023, Elizabeth Czerepak, the Executive Vice President, Chief Business Officer, Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer and Secretary of Scilex Holding Company (the “ Company ”), resigned from the Company, effective immediately.
On September 18, 2023, Ondas Holdings Inc. (the “Company”) appointed Yishay Curelaru as the Company’s Chief Financial Officer, Treasurer and Secretary, effective September 19, 2023
On September 22, 2023, Adam Sragovicz notified Presidio Property Trust, Inc. (the “Company”) of his resignation as Chief Financial Officer, effective immediately.
David Stasse, the Company’s Executive Vice President and Chief Financial Officer, will no longer serve as interim principal accounting officer following Mr. Greene’s appointment.
Mr. David A. Chaika, who was elected as the Interim Chief Financial Officer of the Company effective June 1, 2023, will conclude in such interim role effective October 15, 2023.
On September 21, 2023, the Board of Directors of Masco Corporation (the “Company”) elected Richard Westenberg, 49, as the Company’s Vice President, Chief Financial Officer, effective October 16, 2023.
Departed
Herbert Cross
Chief Financial Officer
Atreca, Inc.
Effective
2023-09-22
Successor
John A. Orwin
Filed
September 21, 2023, 7:59 PM ET
On September 15, 2023, Herbert Cross, Chief Financial Officer of the Company, resigned from his position, effective September 22, 2023 (the “ Separation Date ”), to pursue a new business opportunity.
Appointed
John A. Orwin
principal financial officer
Atreca, Inc.
Effective
2023-09-22
Filed
September 21, 2023, 7:59 PM ET
John A. Orwin, Chief Executive Officer of the Company, was appointed to serve as the principal financial officer of the Company, effective as of the Separation Date.
Departed
Frederick W. Boutin
Chief Executive Officer
TransMontaigne Partners LLC
Effective
2023-10-01
Successor
Randal T. Maffett
Filed
September 21, 2023, 7:59 PM ET
Frederick W. Boutin notified TLP Acquisition Holdings, LLC (“TLP Acquisition”), the indirect 100% owner of TLP, of his intention to retire from his position as Chief Executive Officer of TLP, and its other subsidiaries, effective as of October 1, 2023.
Appointed
Randal T. Maffett
Chief Executive Officer
TransMontaigne Partners LLC
Effective
2023-10-01
Filed
September 21, 2023, 7:59 PM ET
On September 18, 2023, TLP Acquisition appointed Randal T. Maffett (63) as Chief Executive Officer of TLP effective October 1, 2023.
Departed
Chris Palmer
Chief Financial Officer
Moatable, Inc.
Effective
2023-10-16
Filed
September 21, 2023, 7:59 PM ET
On September 17, 2023, Mr. Chris Palmer informed Moatable, Inc. (the “Company”) of his decision to resign as the Company’s Chief Financial Officer, effective as of October 16, 2023.
On September 21, 2023, Andrew Johnson, the Company’s Executive Vice President, Chief Corporate Development Officer, Chief Legal Officer and Secretary, was appointed as the Company’s Interim Chief Financial Officer, effective October 16, 2023.
Departed
Michael Turner
Executive Vice President and Chief Financial Officer
On September 18, 2023, Michael Turner notified 3D Systems Corporation (the “Company”) of his resignation as Executive Vice President and Chief Financial Officer of the Company, effective October 15, 2023, to accept a new career opportunity.
Xuefeng Chen notified Faraday Future Intelligent Electric Inc. (the “Company”), of his decision to resign from his position as Global Chief Executive Officer of the Company effective September 29, 2023. Mr. Chen also resigned from his position as a member of the Board of Directors of the Company (the “Board”) effective September 29, 2023.
Appointed
(interim)
Caihong Qu
Interim Chief Executive Officer and Chief Financial Officer and Director
Tengjun Biotechnology Corp.
Effective
2023-08-10
Filed
September 21, 2023, 7:59 PM ET
On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company
Departed
Lee Trink
Chief Executive Officer
FaZe Holdings Inc.
Effective
2023-09-09
Filed
September 21, 2023, 7:59 PM ET
the Board of Directors of the Company (the “Board”) took action to terminate Lee Trink from his position as Chief Executive Officer of the Company, effective immediately.
entered into a separation agreement with James Giordano, covering his resignation from the office of Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.